Loading…
PROLONGED DONOR HEART CORRECTED QT INTERVAL: IS THERE A RISK?
Post-Htx outcomes included 1-yr survival, 1-yr freedom from any treated rejection, 1-yr freedom from CAV defined as stenosis >= 30%, and 1-yr freedom from Non-Fatal Major Adverse Cardiac Events (NF-MACE: myocardial infarction, new congestive heart failure, percutaneous coronary intervention, impl...
Saved in:
Published in: | Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.1372-1372 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Post-Htx outcomes included 1-yr survival, 1-yr freedom from any treated rejection, 1-yr freedom from CAV defined as stenosis >= 30%, and 1-yr freedom from Non-Fatal Major Adverse Cardiac Events (NF-MACE: myocardial infarction, new congestive heart failure, percutaneous coronary intervention, implantable cardioverter defibrillator/pacemaker implant, stroke). |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/S0735-1097(16)31373-0 |